BOSTON, July 19, 2021 (World NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a medical stage biopharmaceutical corporation focused on developing medicine that meaningfully boost the
BOSTON, July 19, 2021 (World NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a medical stage biopharmaceutical corporation focused on developing medicine that meaningfully boost the